The Journal of Immunology, Vol 143, Issue 3 952-955, Copyright © 1989 by American Association of Immunologists

ARTICLES

Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases

RL Barker, DA Loegering, RM Ten, KJ Hamann, LR Pease and GJ Gleich
Department of Immunology, Mayo Medical School, Rochester, MN 55905.

Human eosinophil granules contain several basic proteins including eosinophil cationic protein (ECP), eosinophil-derived neurotoxin (EDN) and major basic protein (MBP). ECP and MBP are potent helminthotoxins while EDN is less so. Both ECP and EDN possess neurotoxic and ribonuclease activities. A clone representing ECP mRNA was isolated from an eosinophil lambda ZAP cDNA library. The cDNA sequence codes for a preprotein of 160 amino acids and a protein of 133 amino acids, the amino terminus of which is identical to the known partial amino acid sequence of ECP. The ECP nucleotide sequence shows similarity to EDN, rat pancreatic ribonuclease, and human angiogenin; all are members of the ribonuclease gene superfamily. Although the deduced amino acid sequence of ECP shares identical active site and substrate binding site residues with EDN, angiogenin, and human pancreatic ribonuclease, the ribonuclease activity of ECP is 50 to 100 times less than that of EDN possibly because of the lack of a positively charged residue at human pancreatic ribonuclease position 122. The calculated isoelectric point (10.8), electronic charge (14.5), and cationic charge distribution of ECP are different from those of EDN but similar to those of MBP, which may account in part for the greater helminthotoxic activity of ECP when compared to EDN. These data suggest that ECP and EDN are derived from a common ancestral ribonuclease gene and that ECP has evolved into a potent helminthotoxin similar in some respects to MBP, while losing much of its ribonuclease activity.

This article has been cited by other articles:

				H. F. Rosenberg RNase A ribonucleases and host defense: an evolving story J. Leukoc. Biol., May 1, 2008; 83(5): 1079 - 1087. [Abstract] [Full Text] [PDF]

				J. Eriksson, C. Woschnagg, E. Fernvik, and P. Venge A SELDI-TOF MS study of the genetic and post-translational molecular heterogeneity of eosinophil cationic protein J. Leukoc. Biol., December 1, 2007; 82(6): 1491 - 1500. [Abstract] [Full Text] [PDF]

				N. Potenza, V. Salvatore, A. Migliozzi, V. Martone, V. Nobile, and A. Russo Hybridase activity of human ribonuclease-1 revealed by a real-time fluorometric assay Nucleic Acids Res., May 31, 2006; 34(10): 2906 - 2913. [Abstract] [Full Text] [PDF]

				I. Bachelet, A. Munitz, A. Moretta, L. Moretta, and F. Levi-Schaffer The Inhibitory Receptor IRp60 (CD300a) Is Expressed and Functional on Human Mast Cells J. Immunol., December 15, 2005; 175(12): 7989 - 7995. [Abstract] [Full Text] [PDF]

				S. Castella, S. Fouchecourt, A. P. Teixeira-Gomes, J. Vinh, M. Belghazi, F. Dacheux, and J.-L. Dacheux Identification of a Member of a New RNase A Family Specifically Secreted by Epididymal Caput Epithelium Biol Reprod, February 1, 2004; 70(2): 319 - 328. [Abstract] [Full Text] [PDF]

				S. A. Benner The past as the key to the present: Resurrection of ancient proteins from eosinophils PNAS, April 16, 2002; 99(8): 4760 - 4761. [Full Text] [PDF]

				Y.-D. Liao, H.-C. Huang, Y.-J. Leu, C.-W. Wei, P.-C. Tang, and S.-C. Wang Purification and cloning of cytotoxic ribonucleases from Rana catesbeiana (bullfrog) Nucleic Acids Res., November 1, 2000; 28(21): 4097 - 4104. [Abstract] [Full Text] [PDF]

				H.-U. Simon, M. Weber, E. Becker, Y. Zilberman, K. Blaser, and F. Levi-Schaffer Eosinophils Maintain Their Capacity to Signal and Release Eosinophil Cationic Protein Upon Repetitive Stimulation with the Same Agonist J. Immunol., October 1, 2000; 165(7): 4069 - 4075. [Abstract] [Full Text] [PDF]

				M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF]

				M. M. Hamalainen, J. U. Eskola, J. Hellman, and K. Pulkki Major Interference from Leukocytes in Reverse Transcription-PCR Identified as Neurotoxin Ribonuclease from Eosinophils: Detection of Residual Chronic Myelogenous Leukemia from Cell Lysates by Use of an Eosinophil-depleted Cell Preparation Clin. Chem., April 1, 1999; 45(4): 465 - 471. [Abstract] [Full Text] [PDF]

				T. B. van Dijk, E. Caldenhoven, J. A.M. Raaijmakers, J.-W. J. Lammers, L. Koenderman, and R. P. de Groot The Role of Transcription Factor PU.I in the Activity of the Intronic Enhancer of the Eosinophil-Derived Neurotoxin (RNS2) Gene Blood, March 15, 1998; 91(6): 2126 - 2132. [Abstract] [Full Text] [PDF]

				H.-C. Huang, S.-C. Wang, Y.-J. Leu, S.-C. Lu, and Y.-D. Liao The Rana catesbeiana rcr Gene Encoding a Cytotoxic Ribonuclease. TISSUE DISTRIBUTION, CLONING, PURIFICATION, CYTOTOXICITY, AND ACTIVE RESIDUES FOR RNase ACTIVITY J. Biol. Chem., March 13, 1998; 273(11): 6395 - 6401. [Abstract] [Full Text] [PDF]

				H. F. Rosenberg and K. D. Dyer Eosinophil Cationic Protein and Eosinophil-derived Neurotoxin J. Biol. Chem., September 15, 1995; 270(37): 21539 - 21544. [Abstract] [Full Text] [PDF]

				H. F. Rosenberg and H. F. Rosenberg Recombinant Human Eosinophil Cationic Protein J. Biol. Chem., April 7, 1995; 270(14): 7876 - 7881. [Abstract] [Full Text] [PDF]